No Data
Company Q&A | Sinovac Biotech: The company's overseas commercialization network now covers nearly 70 countries and regions worldwide.
Gelonghui, May 25 | An investor asked on the investor interaction platform: Please disclose the registration timelines for your overseas business products in key countries. C-Sword Pharmaceuticals responded that due to significant differences in pharmaceutical regulatory frameworks and review systems across countries and regions globally, the registration timeline for overseas products is not a fixed standard but is dynamically adjusted according to the regulatory requirements of each target market. Leveraging over two decades of experience in overseas markets, the company has established an efficient registration system. One of the core competitive advantages of its international platform is the capability to simultaneously initiate registrations in multiple countries.
Express News | Markets rebounded amid volatility, with the STAR Market 200 Index rising nearly 4% to lead major broad-based indices. The E Fund STAR Market 200 ETF (588270) offers investors exposure to the rebound potential of small-cap stocks on the STAR Market.
Express News | SSE STAR Market Close: PCB-related Stocks Surge Collectively; Innovative Drug Sector Underperforms
Express News | Sci-Tech Innovation Board Market Recap: Semiconductor Leaders Rally Sharply; Innovative Drugs and Medical Devices Sectors Under Pressure
IQVIA: Collaboration Is Designed to Support Kexing's Global Expansion by Bringing Together IQVIA's End-to-End Capabilities Across the Development Lifecycle >IQV
Optical Fiber Bull Stock Clarification: The Company Has No Business Relationship with NVIDIA! | After-Hours Announcement Highlights
Optical fiber stock urgently clarifies no connection with NVIDIA! Stock with five limit-up days in seven trading sessions issues risk warning; pharmaceutical giant announces its holding subsidiary has signed an exclusive option agreement.